Oral microbiome and treatment resistance status in schizophrenia: a cross-sectional study

Anoop Sankaranarayanan; Preethi Ramanathan; Martha Zakrzewski; Deepali Vasani; Ramanathan Ganapathy; Vlasios Brakoulias; Mark W. Douglas

doi:10.1177/02537176241255725

Oral microbiome and treatment resistance status in schizophrenia: a cross-sectional study

Anoop Sankaranarayanan
, Preethi Ramanathan
, Martha Zakrzewski
, Deepali Vasani
, Ramanathan Ganapathy
, Vlasios Brakoulias
, Mark W. Douglas

School of Medicine

Western Sydney Local Health District
Australian Genome Research Facility Ltd.
The University of Sydney

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

4 Downloads (Pure)

Abstract

Early identification may lead to improved outcomes in treatment- resistant schizophrenia (TRS), a condition otherwise associated with worse clinical and functional outcomes.2 Microbiomes, both gut and oral, influence brain functioning via the hypothalamic–pituitary–adrenal (HPA) axis, vagus nerve, tryptophan metabolism, and immune modulation, which makes them a biomarker candidate for TRS.

Original language	English
Pages (from-to)	97-99
Number of pages	3
Journal	Indian Journal of Psychological Medicine
Volume	47
Issue number	1
DOIs	https://doi.org/10.1177/02537176241255725
Publication status	Published - Jan 2025

Access to Document

10.1177/02537176241255725Licence: CC BY-NC

Full textFinal published version, 897 KBLicence: CC BY-NC

Cite this

@article{7b1b01a9c4434b89a3620afc34c6b77d,

title = "Oral microbiome and treatment resistance status in schizophrenia: a cross-sectional study",

abstract = "Early identification may lead to improved outcomes in treatment- resistant schizophrenia (TRS), a condition otherwise associated with worse clinical and functional outcomes.2 Microbiomes, both gut and oral, influence brain functioning via the hypothalamic–pituitary–adrenal (HPA) axis, vagus nerve, tryptophan metabolism, and immune modulation, which makes them a biomarker candidate for TRS.",

author = "Anoop Sankaranarayanan and Preethi Ramanathan and Martha Zakrzewski and Deepali Vasani and Ramanathan Ganapathy and Vlasios Brakoulias and Douglas, \{Mark W.\}",

year = "2025",

month = jan,

doi = "10.1177/02537176241255725",

language = "English",

volume = "47",

pages = "97--99",

journal = "Indian Journal of Psychological Medicine",

issn = "0253-7176",

publisher = "SAGE Publications Ltd",

number = "1",

}

TY - JOUR

T1 - Oral microbiome and treatment resistance status in schizophrenia

T2 - a cross-sectional study

AU - Sankaranarayanan, Anoop

AU - Ramanathan, Preethi

AU - Zakrzewski, Martha

AU - Vasani, Deepali

AU - Ganapathy, Ramanathan

AU - Brakoulias, Vlasios

AU - Douglas, Mark W.

PY - 2025/1

Y1 - 2025/1

N2 - Early identification may lead to improved outcomes in treatment- resistant schizophrenia (TRS), a condition otherwise associated with worse clinical and functional outcomes.2 Microbiomes, both gut and oral, influence brain functioning via the hypothalamic–pituitary–adrenal (HPA) axis, vagus nerve, tryptophan metabolism, and immune modulation, which makes them a biomarker candidate for TRS.

AB - Early identification may lead to improved outcomes in treatment- resistant schizophrenia (TRS), a condition otherwise associated with worse clinical and functional outcomes.2 Microbiomes, both gut and oral, influence brain functioning via the hypothalamic–pituitary–adrenal (HPA) axis, vagus nerve, tryptophan metabolism, and immune modulation, which makes them a biomarker candidate for TRS.

UR - https://www.scopus.com/pages/publications/85194914109

U2 - 10.1177/02537176241255725

DO - 10.1177/02537176241255725

M3 - Article

AN - SCOPUS:85194914109

SN - 0253-7176

VL - 47

SP - 97

EP - 99

JO - Indian Journal of Psychological Medicine

JF - Indian Journal of Psychological Medicine

IS - 1

ER -

Oral microbiome and treatment resistance status in schizophrenia: a cross-sectional study

Abstract

Access to Document

Other files and links

Fingerprint

Cite this